Lv2
150 积分 2026-01-08 加入
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
8天前
已完结
Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances
8天前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
11天前
已完结
The Rate of Re-treatment in Patients Treated with Teprotumumab
11天前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
11天前
已完结
Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease
11天前
已完结
Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves’ orbitopathy: a systematic review and meta-analysis
12天前
已完结
Graves’ disease: a new era of pathophysiology-guided therapeutics
16天前
已完结
Graves disease: latest understanding of pathogenesis and treatment options
19天前
已完结
Harnessing diverse tRNAs and AI-guided mining for compact and efficient plant multiplex genome editing
2个月前
已完结
皖公网安备34019202002308
